Wijsenbeek MS - Search Results

1

Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE.

Nakshbandi G, Moor CC, Antoniou K, Cottin V, Hoffmann-Vold AM, Koemans EA, Kreuter M, Molyneaux PL, Wuyts WA, Wijsenbeek MS. Nakshbandi G, et al. Among authors: wijsenbeek ms. BMC Pulm Med. 2023 Feb 2;23(1):51. doi: 10.1186/s12890-023-02336-4. BMC Pulm Med. 2023. PMID: 36732734 Free PMC article.

2

Serum biomarkers in idiopathic pulmonary fibrosis.

van den Blink B, Wijsenbeek MS, Hoogsteden HC. van den Blink B, et al. Among authors: wijsenbeek ms. Pulm Pharmacol Ther. 2010 Dec;23(6):515-20. doi: 10.1016/j.pupt.2010.08.001. Epub 2010 Aug 12. Pulm Pharmacol Ther. 2010. PMID: 20708704 Review.

3

Early Experience of Pirfenidone in Daily Clinical Practice in Belgium and The Netherlands: a Retrospective Cohort Analysis.

Wijsenbeek MS, Grutters JC, Wuyts WA. Wijsenbeek MS, et al. Adv Ther. 2015 Jul;32(7):691-704. doi: 10.1007/s12325-015-0225-1. Epub 2015 Jul 15. Adv Ther. 2015. PMID: 26173796 Free PMC article.

4

European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers.

Bonella F, Wijsenbeek M, Molina-Molina M, Duck A, Mele R, Geissler K, Wuyts W. Bonella F, et al. Eur Respir J. 2016 Feb;47(2):597-606. doi: 10.1183/13993003.01204-2015. Epub 2015 Nov 19. Eur Respir J. 2016. PMID: 26585424 Free article.

5

Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives.

Kreuter M, Bonella F, Wijsenbeek M, Maher TM, Spagnolo P. Kreuter M, et al. Biomed Res Int. 2015;2015:329481. doi: 10.1155/2015/329481. Epub 2015 Dec 8. Biomed Res Int. 2015. PMID: 26779535 Free PMC article. Review.

6

Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.

Kreuter M, Wijsenbeek MS, Vasakova M, Spagnolo P, Kolb M, Costabel U, Weycker D, Kirchgaessler KU, Maher TM. Kreuter M, et al. Among authors: wijsenbeek ms. Eur Respir J. 2016 Jun;47(6):1776-84. doi: 10.1183/13993003.02087-2015. Epub 2016 Apr 21. Eur Respir J. 2016. PMID: 27103382 Free article. Clinical Trial.

7

Medical Therapy in Idiopathic Pulmonary Fibrosis.

Antoniou KM, Wuyts W, Wijsenbeek M, Wells AU. Antoniou KM, et al. Semin Respir Crit Care Med. 2016 Jun;37(3):368-77. doi: 10.1055/s-0036-1582010. Epub 2016 May 27. Semin Respir Crit Care Med. 2016. PMID: 27231861 Review.

8

New insights on patient-reported outcome measures in idiopathic pulmonary fibrosis: only PROMises?

Wijsenbeek M, van Manen M, Bonella F. Wijsenbeek M, et al. Curr Opin Pulm Med. 2016 Sep;22(5):434-41. doi: 10.1097/MCP.0000000000000294. Curr Opin Pulm Med. 2016. PMID: 27333428 Review.

9

European idiopathic pulmonary fibrosis Patient Charter: a missed opportunity.

Bonella F, Wijsenbeek M, Molina-Molina M, Duck A, Mele R, Geissler K, Wuyts W. Bonella F, et al. Eur Respir J. 2016 Jul;48(1):283-4. doi: 10.1183/13993003.00604-2016. Eur Respir J. 2016. PMID: 27365516 Free article. No abstract available.

10

Cough in idiopathic pulmonary fibrosis.

van Manen MJ, Birring SS, Vancheri C, Cottin V, Renzoni EA, Russell AM, Wijsenbeek MS. van Manen MJ, et al. Among authors: wijsenbeek ms. Eur Respir Rev. 2016 Sep;25(141):278-86. doi: 10.1183/16000617.0090-2015. Eur Respir Rev. 2016. PMID: 27581827 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page